Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rutten

Showing results (171-180 of 204) with videos related to

Pageof 21
Sort By:
Journal of Neurotrauma|September 26, 2018
Multipotent Adult Progenitor Cells, but Not Tissue Inhibitor of Matrix Metalloproteinase-3, Increase Tissue Sparing and Reduce Urological Complications following Spinal Cord InjuryJames M Jones, Marc A DePaul, Cynthia R Gregory, et al.
The European Journal of Surgery = Acta Chirurgica|July 3, 1999
Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer GroupE Kapiteijn, E K Kranenbarg, W H Steup, et al.
Primary Care Diabetes|September 26, 2008
Easily obtainable clinical features increase the diagnostic accuracy for latent autoimmune diabetes in adults: an evidence-based reportMaurice W M D Lutgens, Melanie Meijer, Babette Peeters, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 14, 2024
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the NetherlandsMicha J Pilz, Simon Seyringer, Lára R Hallsson, et al.
The British Journal of Surgery|December 8, 2004
Risk factors for anastomotic failure after total mesorectal excision of rectal cancerK C M J Peeters, R A E M Tollenaar, C A M Marijnen, et al.
The Journal of Surgical Research|August 1, 1996
Establishment of human colonic epithelial cells in long-term cultureC W Deveney, L Rand-Luby, M J Rutten, et al.
Annals of Surgical Oncology|April 5, 2008
Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancerRaphaëla C Dresen, Marleen J Gosens, Hendrik Martijn, et al.
Diseases of the Colon and Rectum|September 8, 2016
No Difference in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The NetherlandsAmanda C R K Bos, Felice N van Erning, Marloes A G Elferink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trialChristian Wallner, Marilyne M Lange, Bert A Bonsing, et al.
The British Journal of Surgery|June 21, 2007
Risk factors for faecal incontinence after rectal cancer treatmentM M Lange, M den Dulk, E R Bossema, et al.
Pageof 21

Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Journal of Neurotrauma|September 26, 2018
Multipotent Adult Progenitor Cells, but Not Tissue Inhibitor of Matrix Metalloproteinase-3, Increase Tissue Sparing and Reduce Urological Complications following Spinal Cord InjuryJames M Jones, Marc A DePaul, Cynthia R Gregory, et al.
The European Journal of Surgery = Acta Chirurgica|July 3, 1999
Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer GroupE Kapiteijn, E K Kranenbarg, W H Steup, et al.
Primary Care Diabetes|September 26, 2008
Easily obtainable clinical features increase the diagnostic accuracy for latent autoimmune diabetes in adults: an evidence-based reportMaurice W M D Lutgens, Melanie Meijer, Babette Peeters, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 14, 2024
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the NetherlandsMicha J Pilz, Simon Seyringer, Lára R Hallsson, et al.
The British Journal of Surgery|December 8, 2004
Risk factors for anastomotic failure after total mesorectal excision of rectal cancerK C M J Peeters, R A E M Tollenaar, C A M Marijnen, et al.
The Journal of Surgical Research|August 1, 1996
Establishment of human colonic epithelial cells in long-term cultureC W Deveney, L Rand-Luby, M J Rutten, et al.
Annals of Surgical Oncology|April 5, 2008
Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancerRaphaëla C Dresen, Marleen J Gosens, Hendrik Martijn, et al.
Diseases of the Colon and Rectum|September 8, 2016
No Difference in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The NetherlandsAmanda C R K Bos, Felice N van Erning, Marloes A G Elferink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trialChristian Wallner, Marilyne M Lange, Bert A Bonsing, et al.
The British Journal of Surgery|June 21, 2007
Risk factors for faecal incontinence after rectal cancer treatmentM M Lange, M den Dulk, E R Bossema, et al.
Pageof 21